[Screening for prostate cancer by measuring PSA level: divergent recommendations, medico- legal uncertainty].

Screening for prostate cancer by measuring psa level :divergent recommendations, medico- legal uncertainty. Screening for prostate cancer by measuring PSA levels has led to different assessments, giving rise to divergent recommendations of good practice. Those recommendations, based on scientific data, are binding in principle and enforceable against practitioners. However, which of these should be followed when they do not match? In this case, a simple and definite answer is difficult to give, which will most certainly disappoint practitioners' anxious expectations. Freedom of medical prescription, a fundamental principle practitioners can rely on in this uncertain context, should allow them to act, case by case, in the best interests of their patients, which they should have informed as objectively as possible.